| Name | Title | Contact Details |
|---|
AerovectRx Corporation is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The MetroHealth System is an essential health system committed to providing health care to everyone in Cuyahoga County, Ohio, and improving the health of the community overall. Its 6,700 employees deliver care to everyone at its main campus, just west of downtown Cleveland, and at more than 20 other MetroHealth locations. It also provides health care at more than 20 additional sites in Cuyahoga County through community partnerships such as the School Health Program. MetroHealth is home to Cuyahoga County`s only verified Level I Adult Trauma Center and Level II Pediatric Trauma Center, and it is the only adult and pediatric burn center in the state of Ohio verified by the American Burn Association and the Committee on Trauma of the American College of Surgeons. In the past year, MetroHealth provided more than one million patient visits in its hospital and health centers. MetroHealth also is an academic medical center committed to teaching and research; each of its active physicians holds a faculty appointment at Case Western Reserve University School of Medicine. MetroHealth has earned Magnet status, which places it in the top 6 percent of all hospitals nationwide for nursing excellence. The MetroHealth System makes every effort to ensure that in every phase of the recruitment and selection process, equal employment is provided to all individuals, regardless of race, color, gender, sex, age, creed, disability, national origin or citizenship, veteran`s status, sexual orientation, gender identity, religious affiliation, socio-economic standing, pregnancy and/or genetic information, and any other protected characteristic. MetroHealth`s mission is, “Leading the way to a healthier you and a healthier community through service, teaching, discovery and teamwork.”
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Molecular Bio-Products is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Modern Fertility tests are exclusively intended to be used for wellness purposes. The tests we offer are not intended to diagnose or treat disease, or to substitute for a physician`s consultation. Our tests are not available in New York, New Jersey, or Rhode Island.